Skip to main content
Fig. 4 | Breast Cancer Research

Fig. 4

From: In patients with metastatic breast cancer the identification of circulating tumor cells in epithelial-to-mesenchymal transition is associated with a poor prognosis

Fig. 4

Survival curves. a Kaplan–Meier estimator plots in terms of OS from stage IV diagnosis (upper panel), OS from CTC assessment (middle panel), and PFS (lower panel) in patients with MBC for those with a fraction of EM CTC above the 75th percentile (dotted red line) and for those with a fraction of EM CTC less than or equal to the 75th percentile (solid black line) before initiation of a new line of therapy. b Kaplan–Meier estimates in terms of OS from stage IV diagnosis (upper panel), OS from CTC assessment (middle panel), and PFS (lower panel) in patients with MBC for those with a fraction of MES above the 50th percentile (dotted green line) and for those with a fraction of MES less than or equal to the 50th percentile (solid orange line) before initiation of a new line of therapy. CTC circulating tumor cells, OS overall survival, PFS progression-free survival. (Color figure online)

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us